World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT02221531
Date of registration: 19/08/2014
Prospective Registration: No
Primary sponsor: University Hospital, Basel, Switzerland
Public title: Carbetocin Trial: Carbetocin Appropriate Rate Better Equilibrium Between Tonus (TOnus) and CIrculatioN CARBETOCIN
Scientific title: Double-blind Randomised Non-inferiority Trial to Assess Efficacy and Safety of Carbetocin After Caesarean Section Applied as Iv-bolus as Compared to a Short-infusion
Date of first enrolment: August 2014
Target sample size: 140
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02221531
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).  
Phase:  Phase 4
Countries of recruitment
Switzerland
Contacts
Name:     Salome Dell-Kuster, MD
Address: 
Telephone:
Email:
Affiliation:  Department of Anaesthesiology, University Hospital Basel, Switzerland
Key inclusion & exclusion criteria

Inclusion Criteria:

- healthy women

- singleton pregnancy

- caesarean section under regional anaesthesia

- older than 18 years

- written informed consent

Exclusion Criteria:

- emergency caesarean section

- secondary caesarean section due to fetal distress

- comorbidities (cardiovascular, kidney or liver disorder, epilepsy)

- obstetric diseases (hypertension, (pre-)eclampsia)

- uterine malformation (including uterine fibroids)

- bleeding disorder

- known hypersensitivity to carbetocin or oxytocin

- fetal malformation



Age minimum: 18 Years
Age maximum: 46 Years
Gender: Female
Health Condition(s) or Problem(s) studied
Complications; Cesarean Section
Anesthesia; Reaction
Intervention(s)
Drug: Carbetocin Short-infusion
Drug: Carbetocin Bolus application
Primary Outcome(s)
Maximal uterine tone [Time Frame: within the first 5 minutes after cord clamping]
Secondary Outcome(s)
Mean arterial pressure [Time Frame: within first five minutes after cord clamping]
Secondary ID(s)
2014-088
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Obstetric Anaesthetists' Association United Kingdom
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history